SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001654954-21-004510
Filing Date
2021-04-22
Accepted
2021-04-22 06:03:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-1 gtbp_s-1.htm S-1 618983
2 OPINION OF BAKER & MCKENZIE LLP gtbp_ex5-1.htm EX-5.1 13767
3 CONSENT OF SELIGSON & GIANNATTASIO, LLP gtbp_ex23-1.htm EX-23.1 4444
4 CONSENT OF WEINBERG & COMPANY gtbp_ex23-2.htm EX-23.2 4401
5 IMAGE gtbp_s-1000.jpg GRAPHIC 1675
  Complete submission text file 0001654954-21-004510.txt   645331
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-255429 | Film No.: 21843145
SIC: 2834 Pharmaceutical Preparations